Dr. Sarin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-721-3476
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2009 - 2012
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2008 - 2009
- Stanford University School of MedicinePh.D., Genetics, 2008 - 2009
- Stanford University School of MedicineClass of 2008
- Stanford UniversityPhD, Genetics, 2000 - 2006
- Stanford UniversityB.S., Computer Science, 1996 - 2000
Certifications & Licensure
- CA State Medical License 2009 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Medical Career Development Award Dermatology Foundation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- F32 NRSA Ruth L. Kirschstein National Research Service Awards NIH, 2013
- Join now to see all
Clinical Trials
- Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer Start of enrollment: 2018 Jul 07
- Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Start of enrollment: 2018 Dec 01
- Complement C5a Receptors in Hidradenitis Suppurativa Start of enrollment: 2019 Jul 18
Publications & Presentations
PubMed
- 8 citationsWays to Improve Care for LGBT Patients in Dermatology Clinics.Justin L. Jia, Danielle J. Polin, Kavita Y. Sarin
Dermatologic Clinics. 2020-04-01 - 70 citationsNoncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomasRamon J. Whitson, Alexander Lee, Nicole M. Urman, A. Mirza, C. Yao
Nature Medicine. 2018-02-05 - 69 citationsEffects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.Mina S. Ally, Katherine J. Ransohoff, Kavita Y. Sarin, Scott X. Atwood, Melika Rezaee
JAMA Dermatology. 2016-04-01
Journal Articles
- Sexual and Gender Minority Curricula Within US Dermatology Residency ProgramsKristin M Nord, Kavita Y Sarin, JAMA Dermatology
- Dermatomyositis associated with capecitabine in the setting of malignancyChen FW, Zhou X, Egbert BM, Swetter SM, Sarin KY, J Am Acad Dermatol, 1/1/2014
- Activating HRAS Mutation in Nevus SpilusSarin KY, McNiff JM, Kwok S, Kim J, Khavari PA, J Invest Dermatol, 1/1/2014
- Join now to see all
Press Mentions
- Mobile App Helps Detect Skin Cancer in Older PatientsJuly 18th, 2022
- New Gel Shows Promise Against BCCAugust 12th, 2021
- Positive Data from the Remetinostat Phase II Study in Basal Cell Carcinoma Published in Clinical Cancer ResearchAugust 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: